Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial-Reference-Cited by-同舟云学术

Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial

Published:2007-02 Issue:2 Volume:18 Page:263-268
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ferrero J.-M.,Weber B.,Geay J.-F.,Lepille D.,Orfeuvre H.,Combe M.,Mayer F.,Leduc B.,Bourgeois H.,Paraiso D.,Pujade-Lauraine E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/2/263/694472/mdl376.pdf

Reference26 articles.

1. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer; the ICON4/AGO-OVAR-2.2 trial;The;Lancet,2003

2. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med,1996

3. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer;Piccart;Int J Gynecol Cancer,2003

4. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study;Muggia;J Clin Oncol,2000

5. Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer;Neijt;J Clin Oncol,2000

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial;The Lancet Oncology;2024-09

2. MODERN APPROACHES TO THE SYSTEMIC TREATMENT OF RECURRENT OVARIAN CANCER;THE NEW ARMENIAN MEDICAL JOURNAL;2023-04-24

3. Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer;Holland‐Frei Cancer Medicine;2022-10-21

4. TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer;BIOIMPACTS;2022

5. Chemotherapeutic Protocols for the Treatment of Gynecological Cancer;Chemotherapy Protocols and Infusion Sequence;2022